The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical activity and safety of penpulimab (Anti-PD-1) with anlotinib as first-line therapy for advanced hepatocellular carcinoma (HCC).
 
Shun Chang Jiao
No Relationships to Disclose
 
Li Bai
No Relationships to Disclose
 
Jiahong Dong
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Chunhong Hu
No Relationships to Disclose
 
Liangfang Shen
No Relationships to Disclose
 
Qun Qin
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Jia Fan
No Relationships to Disclose
 
Aimin Zang
No Relationships to Disclose
 
Chun Han
No Relationships to Disclose
 
Yanyun Zhu
No Relationships to Disclose
 
Juan Li
No Relationships to Disclose
 
Pengfei Zhang
No Relationships to Disclose
 
Sisi Ye
No Relationships to Disclose
 
Xindan Kang
No Relationships to Disclose
 
Qian Qiao
No Relationships to Disclose
 
Weifeng Song
No Relationships to Disclose
 
Baiyong Li
No Relationships to Disclose
 
Yu Xia
No Relationships to Disclose